top of page

 

Pralsetinib is a medication used to treat a type of cancer called non-small cell lung cancer (NSCLC) and thyroid cancer. It belongs to a class of drugs known as kinase inhibitors, which work by blocking specific proteins in cancer cells that help them grow and spread.

 

NSCLC and thyroid cancer can sometimes have changes, or mutations, in a gene called RET. These mutations can make cancer cells grow faster and spread to other parts of the body. Pralsetinib works by targeting these mutated RET proteins, which helps slow down or stop the growth of cancer cells.

 

Pralsetinib is usually taken orally, in the form of capsules, once a day. Our doctor will determine the right dose for you based on factors like your weight, overall health, and how well you tolerate the medication.

Like all medications, Pralsetinib can cause side effects, although not everyone will experience them or to the same extent. Common side effects may include fatigue, nausea, diarrhea, muscle or joint pain, high blood pressure, and changes in liver function tests. These side effects can often be managed with supportive care and may improve over time as your body adjusts to the medication.

 

Before starting treatment with Pralsetinib, our doctor will perform tests to check for the presence of RET mutations and to assess your overall health. It's essential to inform our doctor about any other medical conditions you have and any other medications or supplements you are taking, as they may interact with Pralsetinib.

 

During treatment, your doctor will monitor you closely for any signs of side effects or complications. They may also perform regular tests to check how well the medication is working and to adjust your dose if needed.

Pralsetinib has shown promising results in clinical trials, with many patients experiencing significant tumor shrinkage and prolonged periods of disease control. However, it's essential to remember that individual responses to treatment can vary, and not everyone will respond in the same way.

 

In conclusion, Pralsetinib is a medication used to treat non-small cell lung cancer and thyroid cancer that has mutations in the RET gene. By targeting these mutated proteins, Pralsetinib helps slow down or stop the growth of cancer cells, offering hope to patients with these challenging conditions. As with any medication, it's essential to discuss the potential benefits and risks of Pralsetinib with your doctor to determine if it's the right treatment option for you.

Have any queries, book a consultation with our Oncology Clinical Specialist

Pralsetinib

₹500.00Price
  • Pralsetinib is like a superhero that targets and fights a specific villain in your body called RET. In certain types of cancer, like non-small cell lung cancer and thyroid cancer, there's a gene called RET that goes a bit haywire, causing cancer cells to grow and spread more than they should.

    Now, Pralsetinib steps in and says, "Hey, RET, you're causing trouble!" It works by blocking RET, preventing it from telling cancer cells to grow uncontrollably. By doing this, Pralsetinib helps slow down or even stop the cancer from spreading further.

    So, in simple terms, Pralsetinib is like a warrior that battles the bad guy RET, giving your body a better chance to fight off the cancer.

    Have any queries, book a consultation with our Oncology Clinical Specialist

bottom of page